Harnessing Natural gd T-cell Receptors (gd TCR) to Develop Effective Cellular Therapies for Solid Tumors

Time: 11:45 am
day: Day 2 - Track A - Morning


• Understanding the unique cancer targeting properties of γδ TCRs
• Advantages of using engineered αβT cells engineered to express a defined tumor-reactive natural γδ TCR (TEG)
• Broadly applicability of γδ TCRs for building allogeneic T cell platforms that retain native recognition and signaling properties